These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9207984)

  • 1. Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterol.
    Cimminiello C; Vigorelli P; Piliego T; Soncini M; Toschi V; Arpaia G; Perolini S; Bonfardeci C
    Biomed Pharmacother; 1997; 51(4):164-9. PubMed ID: 9207984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.
    Avellone G; Di Garbo V; Cordova R; Piliego T; Raneli G; De Simone R; Bompiani GD
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):543-8. PubMed ID: 7578896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance.
    Jeng JR; Jeng CY; Sheu WH; Lee MM; Huang SH; Shieh SM
    Am Heart J; 1997 Sep; 134(3):565-71. PubMed ID: 9327717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels.
    Bröijersen A; Eriksson M; Wiman B; Angelin B; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):511-6. PubMed ID: 8624772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of reduction of plasma triglycerides with gemfibrozil on high-density-lipoprotein-cholesterol concentrations.
    Rubins HB; Robins SJ
    J Intern Med; 1992 Apr; 231(4):421-6. PubMed ID: 1588269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemfibrozil predictably lowers triglycerides but does not significantly change plasminogen activator inhibitor activity in hypertriglyceridemic patients with a history of thrombosis.
    Haire WD
    Thromb Res; 1991 Nov; 64(4):493-501. PubMed ID: 1788834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemia.
    Asplund-Carlson A
    J Cardiovasc Risk; 1996 Aug; 3(4):385-90. PubMed ID: 8946270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulofibrinolytic assessment of effects of bezafibrate on hypertriglyceridemia in postmenopausal women.
    Ushiroyama T; Ikeda A; Higashio S; Ueki M
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):709-14. PubMed ID: 11132648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients.
    Chen MF; Wang TD; Yeh HT; Hsu HC; Lee YT
    Eur J Clin Invest; 2001 Aug; 31(8):707-13. PubMed ID: 11473572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Hung YJ; Pei D; Wu DA; Kuo SW; Fuh MM; Jeng C
    J Formos Med Assoc; 1999 Feb; 98(2):104-10. PubMed ID: 10083765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.
    Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K
    Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in high density lipoprotein cholesterol (HDL-C) levels following gemfibrozil therapy.
    Lacko AG; Kudchodkar BJ; Loney WW; Clearfield MB; Weis S
    Clin Chem Lab Med; 1998 Jun; 36(6):389-92. PubMed ID: 9711427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels.
    Weis S; Kudchodkar BJ; Clearfield MB; Lacko AG
    Artery; 1992; 19(6):353-66. PubMed ID: 1471924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
    Hamsten A; Syvänne M; Silveira A; Luong LA; Nieminen MS; Humphries S; Frick MH; Taskinen MR
    Thromb Haemost; 2000 Mar; 83(3):397-403. PubMed ID: 10744143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM
    Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
    J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study.
    Zema MJ
    J Am Coll Cardiol; 2000 Mar; 35(3):640-6. PubMed ID: 10716466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.
    Ihnken K; Speiser W; Ruf W; Thiel W; Schlepper M; Müller-Berghaus G
    Ann Hematol; 1993 Nov; 67(5):237-44. PubMed ID: 8241347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.